- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | Quipt Home Medical Corp: Quipt Home Medical to release Q2 2024 results May 15 | 1 | Stockwatch | ||
| Mo | Quipt Home Medical Corp. to Announce Fiscal Second Quarter 2024 Financial Results on May 15, 2024 | 1 | GlobeNewswire (USA) | ||
| Fr | Quipt Home Medical Corp. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 02.05. | Quipt Home Medical Corp: Quipt Home to buy back up to 3.62 million shares | 2 | Stockwatch | ||
| 02.05. | Quipt Home Medical Corp.: Quipt Home Medical Announces Normal Course Issuer Bid | 79 | GlobeNewswire (Europe) | CINCINNATI, May 02, 2024 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the "Company") (NASDAQ: QIPT) (TSX: QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care... ► Artikel lesen | |
| 12.04. | Quipt Home Medical Corp. - S-8, Securities to be offered to employees in employee benefit plans | 2 | SEC Filings | ||
| 28.03. | Quipt Home Medical Corp. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 28.03. | Stocks in Play: Quipt Home Medical Corp | 1 | Baystreet.ca | ||
| 28.03. | Quipt Home Medical Corp: Quipt Home shareholders elect four directors at AGM | 1 | Stockwatch | ||
| 28.03. | Quipt Home Medical Corp.: Quipt Home Medical Announces Voting Results from Its Annual General and Special Meeting of Shareholders | 102 | GlobeNewswire (Europe) | CINCINNATI, March 28, 2024 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the "Company") (NASDAQ: QIPT) (TSX: QIPT)?, a U.S. based home medical equipment provider, focused on end-to-end respiratory... ► Artikel lesen | |
| 13.03. | Quipt Home Medical Corp. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 12.03. | Quipt Home Medical Corp.: Quipt Home Medical Announces Participation in the 36th Annual Roth Investor Conference on March 17-19, 2024 | 1 | GlobeNewswire (USA) | ||
| 16.02. | Earnings call: Quipt Home Medical announces robust Q1 2024 financials | 1 | Investing.com | ||
| 15.02. | Quipt Home Medical Corp reports results for the quarter ended in December - Earnings Summary | 2 | Reuters | ||
| 14.02. | Quipt Home Medical GAAP EPS of -$0.01 beats by $0.01, revenue of $65.4M beats by $1.1M | 2 | Seeking Alpha | ||
| 14.02. | Quipt Home Medical Corp: Quipt Home loses $600,000 (U.S.) in Q1 | 1 | Stockwatch | ||
| 14.02. | Quipt Home Medical Corp. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 14.02. | Quipt Home Medical Corp.: Quipt Home Medical Reports Strong Operating Performance With Record First Quarter Fiscal 2024 Financial Results Posting Revenue Growth of 60% and Adjusted EBITDA Growth of 71% | 105 | GlobeNewswire (Europe) | CINCINNATI, Feb. 14, 2024 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the "Company") (NASDAQ: QIPT; TSX: QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care... ► Artikel lesen | |
| 13.02. | Quipt Home Medical Earnings Preview | 1 | Benzinga.com | ||
| 01.02. | Quipt Home Medical Corp. - 6-K, Report of foreign issuer | 1 | SEC Filings |
Seite:
1 2 3 Weiter >>
43 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS MEDICAL CARE | 38,670 | +3,31 % | JPMORGAN stuft FMC FRESENIUS MEDICAL CARE AG & CO KGAA auf 'Underweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Aktie des Dialyseanbieters Fresenius Medical Care (FMC) auf "Underweight" mit einem Kursziel von 35,40 Euro belassen. US-Konkurrent Davita... ► Artikel lesen | |
| VITA 34 | 4,700 | -1,26 % | EQS-News: Vita 34 AG: Vita 34 kehrt 2023 auf Wachstumspfad zurück | EQS-News: Vita 34 AG
/ Schlagwort(e): Jahresergebnis
Vita 34 kehrt 2023 auf Wachstumspfad zurück
30.04.2024 / 22:51 CET/CEST
Für den Inhalt der Mitteilung ist der Emittent... ► Artikel lesen | |
| M1 KLINIKEN | 15,850 | 0,00 % | EQS-Adhoc: M1 Kliniken AG: Aufsichtsrat stellt Jahresabschluss 2023 fest. Dividendenvorschlag in Höhe von EUR 0,50 je Aktie | EQS-Ad-hoc: M1 Kliniken AG / Schlagwort(e): Dividende/Prognose
M1 Kliniken AG: Aufsichtsrat stellt Jahresabschluss 2023 fest. Dividendenvorschlag in Höhe von EUR 0,50 je Aktie
07.05.2024... ► Artikel lesen | |
| HIMS & HERS HEALTH | 11,165 | -1,24 % | Hims & Hers Health, Inc. Reports First Quarter 2024 Financial Results | SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. ("Hims & Hers" or the "Company", NYSE: HIMS), the leading health and wellness platform, today announced financial results for the first... ► Artikel lesen | |
| BAXTER | 33,350 | +0,29 % | Baxter International Inc. Q1 Profit Decreases, but beats estimates | DEERFIELD (dpa-AFX) - Baxter International Inc. (BAX) announced a profit for first quarter that decreased from last year but beat the Street estimates.The company's bottom line came in at $37... ► Artikel lesen | |
| DAVITA | 126,75 | +0,24 % | DaVita Inc. Q1 Profit Increases, beats estimates | WASHINGTON (dpa-AFX) - DaVita Inc. (DVA) revealed earnings for its first quarter that increased from the same period last year and beat the Street estimates.The company's bottom line totaled... ► Artikel lesen | |
| EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc. - 8-K, Current Report | ||
| CO-DIAGNOSTICS | 1,160 | +2,65 % | Co-Diagnostics, Inc. Reports Full Year 2023 Financial Results | SALT LAKE CITY, March 14, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic... ► Artikel lesen | |
| ORPEA | 13,620 | -2,18 % | ORPEA S.A.: Filing of the 2023 Universal Registration Document | Regulatory News:
ORPEA S.A. (the "Company") (Paris:ORP) filed, today, its 2023 Universal Registration Document (document d'enregistrement universel) with the French Autorité des Marchés Financiers... ► Artikel lesen | |
| CYTOSORBENTS | 0,892 | +9,85 % | Cytosorbents Corp - 8-K, Current Report | ||
| SENSEONICS | 0,465 | +4,97 % | Senseonics Holdings, Inc. Announces Data From the Eversense Post Approval Study to Be Presented at the 17th International Conference on Advanced Technologies and Treatments for Diabetes | Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for... ► Artikel lesen | |
| NANO-X IMAGING | 9,500 | 0,00 % | Nano-X Imaging Ltd. - 6-K, Report of foreign issuer | ||
| BIOCEPT | 6,800 | 0,00 % | NSE - BIOCEPT INC - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | ||
| UNIVERSAL HEALTH SERVICES | 158,00 | 0,00 % | UNIVERSAL HEALTH SERVICES INC - 10-Q, Quarterly Report | ||
| DELCATH SYSTEMS | 5,250 | +3,96 % | Delcath Systems, Inc.: Delcath Systems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | NEW YORK, May 3, 2024 /PRNewswire/ -- Delcath Systems, Inc. (Nasdaq: DCTH) (the "Company" or "Delcath"), an interventional oncology company focused on the treatment of primary and metastatic cancers... ► Artikel lesen |
QUIPT HOME MEDICAL CORP gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell +1,50 % bei einem Aktienkurs von 4,070 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
